Enhancing the QUAlity and Transparency Of health Research
Search for reporting guidelines
Use your browser's Back button to return to your search results
Good Publication Practice (GPP) Guidelines for Company -Sponsored Biomedical Research: 2022 Update
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Communicating company sponsored medical research |
| Full bibliographic reference | DeTora LM, Toroser D, Sykes A, Vanderlinden C, Plunkett FJ, Lane T, Hanekamp E, Dormer L, DiBiasi F, Bridges D, Baltzer L, Citrome L. Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update. Ann Intern Med. 2022;175(9):1298-1304. |
| Language | English |
| PubMed ID | 36037471 |
| Applies to the whole report or to individual sections of the report? | Acknowledgements, Conflict of interest, Ethical issues (consent etc.) |
| Previous versions of this guideline / Guideline history | GPP 2022 replaces GPP3 [Battisti et al. 2015: PMID: 26259067], GPP2 [Graf et al. 2009; PMID: 19946142] and GPP [Wager et al. 2003; PMID: 12814125]. |
| Record last updated on | September 27, 2024 |